EW
TECH icon

Evoke Wealth’s Bio-Techne TECH Stock Holding History

Evoke Wealth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60
Closed -$4K – 1059
2022
Q3 		$4K Buy
60
+40
+200% +$3.46K ﹤0.01% 942
2022
Q2 		$2K Sell
20
-24
-55% -$2.25K ﹤0.01% 1079
2022
Q1 		$5K Buy
+44
New +$4.54K ﹤0.01% 924
2020
Q1 		– Sell
-320
Closed -$17.6K – 1338
2019
Q4 		$17.6K Hold
320
– – ﹤0.01% 620
2019
Q3 		$15.7K Buy
+320
New +$16K ﹤0.01% 720

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Evoke Wealth's TECH Position: Q4 2022 in Review

Evoke Wealth sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 60 shares — an estimated $4K sold.

Evoke Wealth first reported a position in TECH in Q3 2019 and held it in 5 quarters. The position peaked at $17.6K in Q4 2019. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Evoke Wealth reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 60 Bio-Techne shares in Q4 2022, an estimated $4K.
  • Evoke Wealth first reported a position in Bio-Techne in Q3 2019 and held it in 5 quarters.
  • Evoke Wealth's Bio-Techne position peaked at $17.6K in Q4 2019.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.